DescriptionResearchers at the University of Maryland School of Medicine (UMSOM) became the first in the United States to begin testing experimental COVID-19 vaccine candidates developed by Pfizer and BioNTech. The research, funded by Pfizer Inc., will study the safety, efficacy, and dosing of an experimental mRNA-based vaccine. Included are a news release and video describing the research.
KeywordCoronavirus Disease 2019 (COVID-19)
University of Maryland, Baltimore. School of Medicine
RNA, Messenger--therapeutic use